Figures & data
Figure 1. (A) XRD of D-nHAp showing hexagonal HAp crystal structure along with the reference patterns of HAp and GdPO4. (B) SEM image of D-nHAp showing particle size ∼50 nm. Inset: DLS data of D-nHAp showing an average size ∼50 nm. (C) Diffuse reflectance spectra showing characteristic features of ICG in D-nHAp samples compared to undoped nHAp. Inset: Digital photograph pf D-nHAp and nHAp solutions (∼20 mg/ml) indicating the greenish body color due to ICG doping. nHAp: hydroxyapatite nanoparticle; D-nHAp: doped nHAp; ICG: indocyanine green.
Figure 11. (A) Immunosuppression studied by cell viability analysis on mononuclear cells exposed to mixture of lectins + nHAp/D-nHAp samples. Optical microscopic images of mononuclear cells treated with (B) 100 µg/mL of D-nHAp + lectins and (C) lectins. The data indicate that nHAp/DnHAp do not interfere with proliferation of mononuclear cells activated by lectins. nHAp: hydroxyapatite nanoparticle; D-nHAp: doped nHAp.
